Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07035847 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Transaxillary TAVR With Solely Echocardiography Guidance

StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Eligibility criteria shortened, about 31 words
    • Study title expanded, about 2 words
    v3
  2. Trial status: Active, Not Recruiting to Recruiting
    • Primary and study completion dates: Jul 1, 2025 to Dec 31, 2026
    • Site details revised
    • Eligibility criteria expanded, about 4 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study aims to evaluate the safety and feasibility of performing transaxillary transcatheter aortic valve replacement (TA TAVR) guided solely by echocardiography in patients with severe aortic stenosis (AS).
Trial Details
NCT Number NCT07035847
Lead Sponsor Chinese Academy of Medical Sciences, Fuwai Hospital
Conditions
(from sponsor)		 Aortic Stenosis
Related terms Aortic Valve Stenosis
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov